2027 Medicare Physician Fee Schedule: The Modifier 25 Impact on Podiatry Practices

Every year CMS releases its reimbursement rules with few changes here and there. In 2027, the Centers for Medicare & Medicaid Services will go through a critical threshold for podiatry practices. In the next year, the outpatient foot and ankle practices face a compounding financial hit driven by two major policy shifts: an expiring statutory funding boost that drops the baseline non-QP conversion factor by 1.68% to $32.8409, alongside a proposed 50% payment slash to the lower-valued code when Modifier 25 is appended for same-day procedures. 

Similarly, the APMA (American Podiatric Medical Association) is projecting an overall 6% drop in podiatric Medicare revenue. These numbers may vary according to the size of the practice and other confounding factors. Deviating from these new rules even modest payment reductions can translate into substantial revenue loss when applied across hundreds or thousands of encounters annually. This guide offers a comprehensive roadmap to practice owners, clinical billers, and administrators on how to calculate financial risk, strengthen audit compliance, and protect operational viability. Being proactive is not just an option, it’s necessary.

Unpacking CMS’s Proposed Modifier 25 Policy Mechanics

In order to proactively deal with upcoming reimbursement challenges, It’s important to understand how the CY 2027 Medicare Physician Fee Schedule proposed rule will impact podiatry practices. Let’s look at how Modifier 25 reimbursement works today versus what CMS is proposing for the future.

Current State vs. Proposed 2027 Framework

Currently, podiatrists receive 100% of the allowable reimbursement for a qualifying E/M visit for CPT 99213 or 99214 alongside 100% payment for a medically necessary minor procedure CPT 11056 for hyperkeratotic lesion removal or CPT 11730 for nail avulsion.

According to the proposed 2027 framework, CMS will pay 100% for the higher-valued service but apply an immediate 50% payment slash to the lower-valued service. This will strip half the value of the service for the E/M code during routine encounters in 2027. This could directly affect encounters that routinely combine patient evaluation with medically necessary treatment. 

CMS’s Overlapping Practice Expense Rationale

On the other hand, CMS justifies the proposed changes as a necessary step to reduce duplicate claim payments that typically occur during same-day E/M visits. CMS has cited the overlapping practice expenses that includes the patient registration, intake vital signs, room setup, and clinical staff support as reasons for reducing payment on one of the services.

Why Podiatry Practices View the Situation Differently

Many podiatrists differ with the CMS opinion because every patient encounter involves many steps before a patient is prepared for a procedure. Healthcare providers frequently assess primary medical conditions like diabetic neuropathy, peripheral vascular disease, infection risks, biomechanical abnormalities, and other underlying conditions before deciding whether treatment is clinically appropriate. The medical decision-making process is separate from performing services such as wound debridement, nail avulsions, or other foot and ankle procedures.

Due to this complex cognitive workload, many podiatry experts believe the proposed Modifier 25 payment reduction may undervalue their work and efforts to deliver comprehensive, same-day patient care.   

Financial Exposure: High-Frequency Podiatry Clinical Scenarios

Quantifying the direct financial impact of modifier 25, 50 percent payment cut is difficult because it does not primarily affect rare or highly specialized services. Instead, its primary focus is on many of the same-day evaluation and treatment combinations that podiatrists perform every day. In podiatry clinics, billing teams frequently pair an E/M service with a medically necessary procedure. The proposed Modifier 25 payment reduction could create cumulative revenue losses across hundreds of patient encounters each month, putting clinicians revenue at risk

Granular Impact Analysis on Core Encounter Types

Here’s how modifier 25 impact on podiatry reimbursement will impact the services rendered by providers:

Diabetic Ulcer Evaluation + Debridement

Combining CPT 99214 (established E/M) with CPT 11042 or 97597 (debridement) faces severe margin erosion. Cutting 50% from the E/M code degrades reimbursement for the comprehensive systemic assessment required for high-risk diabetic wound management.

New Heel Pain Evaluation + Plantar Fascia Injection

Coupling new patient visits (CPT 99023/99204) with therapeutic injections (CPT 20550) slashes onboarding revenue, penalizing clinics for thorough initial diagnostic workups.

Infected Onychocryptosis Evaluation + Immediate Avulsion

Billing CPT 99213 alongside CPT 11730 creates a sharp clinical paradox. Practices are penalized financially for resolving acute pain in one visit rather than forcing vulnerable patients into two separate encounters.

Routine/Mycotic Nail Care with Neuropathic Screening

Pairing CPT 99213 with CPT 11721 threatens the baseline profitability of routine foot care programs in high-volume Medicare practices.

Calculated Financial Exposure (2026 Actual vs. Proposed 2027)

Here’s a snapshot of the debridement and E/M same day Medicare 2027 proposed changes and how it will impact your clinic’s earning:

Broader 2027 MPFS Pressures Impacting Practice Economics

Though, proposed Modifier 25 payment reduction has captured much of the attention surrounding the CMS 2027 Medicare Physician Fee Schedule proposed rule, it is only one component of a broader reimbursement landscape that could reshape podiatry practice economics. There are several other policy changes that may compound the effects on operating costs, compliance obligations, and long-term financial planning.

Practice Expense (PE) Methodology Overhaul

Practice expense PE methodology overhaul 2027 proposes phase-out of the Indirect Practice Expense Composition Index (IPCI), signaling a shift in how Medicare allocates practice expense resources across specialties. 

For many office-based podiatry practices that perform procedures in outpatient settings, changes to practice expense calculations could alter reimbursement dynamics over time. When combined with declining payment rates and rising operational costs, even small adjustments in the practice expense methodology can have a meaningful impact on overall profitability.

New Expectations for RPM and RTM Services

Under the new remote patient monitoring clinical staff employment rules 2027, healthcare facilities offering RPM or Remote Therapeutic Monitoring (RTM) for high-risk complications, like diabetic foot, must comply with strict staffing mandates. CMS proposes clinical staff overlooking patient monitoring staff should be directly employed by the practice. 

Podiatry clinics who are relying on outsourcing patient monitoring to third parties will get no reimbursement for such services. This factor has forced providers to rethink and restructure their RPM services because coming 2027, they will be responsible for the full financial cost on services rendered by third-party staff.    

Preparing for the Shift Toward Specialty MVPs

Another big development is CMS’s evolution away from traditional Merit-based Incentive Payment System (MIPS) reporting toward specialty-focused MIPS Value Pathways (MVPs). Though, this transition opens up new opportunities for the podiatry clinics to demonstrate quality outcomes through measures that better reflect foot and ankle care. Doing this will help practices to protect themselves from MIPS negative payment adjustments. 

Operational Playbook: How Podiatry Practices Must Prepare

Being proactive and deploying the aggressive operational strategies is the only way to ensure operational readiness. As the CMS 2027 Medicare Physician Fee Schedule proposed rule moves through the regulatory process, providers can make clinical, financial, and administrative adjustments before the final changes take effect. 

Conduct an Internal Revenue Exposure Audit

Your first step as a practice manager is to understand how dependent your podiatry practice is on Modifier 25 billing. Immediately extract the previous 12 months of claims data to identify how frequently same-day E/M and procedure combinations occur and what percentage of revenue will be affected by this change. Doing this will help you create a pattern and prioritize areas where risk mitigation will be crucial before the policy change takes effect.   

Strengthen Documentation for Audit Readiness

Accurate clinical documentation is your only defense against Medicare Administrative Contractors (MACs) scrutiny. Configure EHR templates to clearly distinguish the evaluation component from the procedural service. When the chief complaint is separated, detailed history is taken to support a distinct medical decision-making narrative, the E/M services provided becomes medical necessity, making MAC audit risk Modifier 25 podiatry less likely to occur. 

Commercial Payer Alignment

Many commercial insurers like UnitedHealthcare, Aetna, and Humana routinely incorporate Medicare payment reductions. As a proactive practice manager you should review commercial payer Modifier 25 follow-the-leader cuts and contracts to prevent unexpected reimbursement reductions. 

Reevaluate Scheduling and Care Delivery Models

Many podiatry hospitals are facing challenging situations under the proposed Modifier 25 payment reduction system whether to continue same-day comprehensive care or switch to alternative scheduling strategies. To balance compliance requirements, reimbursement realities, and timely access to podiatric care, single-visit treatment often improves patient satisfaction and clinical efficiency. The goal here is simple, preserving patient-centered outcomes while protecting long-term practice viability.

Conclusion & Practice Management Action Checklist

The upcoming CMS 2027 Medicare Physician Fee Schedule highlights how vulnerable podiatry practices can be to policy changes that affect same-day evaluation and procedural care. While nothing has been finalized yet. It’s the best time for providers to become proactive and strengthen documentation, measure Modifier 25 revenue exposure, and evaluate operational workflows that support both compliance and financial stability. Practices adapting to this situation will be in the best position to absorb reimbursement shifts while continuing to deliver efficient, patient-centered care. 

Are feeling anxious about CMS physician fee schedule changes? Improve your compliance with 2017 medicare reimbursement rules by outsourcing Billingpodiatry company to proactively resolve revenue cycle and modifier 25 E/M issues and get full value reimbursement for same day services. Book your free appointment today. 

Practice Manager Action Checklist

• Run EHR Exposure Query: Extract 12 months of CPT 99202–99215 claims paired with 0-, 10-, or 90-day global procedures.
• Harden EHR Note Templates: Enforce distinct Chief Complaints, isolated HPIs, and independent MDMs for same-day E/M visits.
• Re-model Operating Budgets: Calculate practice-specific revenue baseline drops using the proposed $32.8409 conversion factor.
• Audit RPM/RTM Workflows: Ensure all clinical remote monitoring staff are directly employed by your practice.